Tuesday, March 04, 2025 | 07:10 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

USFDA inspects Lupin's Pithampur Unit-3 (Indore) facility

Image

Capital Market

Issues five observations

Lupin announced the completion of a US FDA inspection carried out at its Pithampur Unit-3 (Indore) facility. The inspection was a GMP inspection for the facility and also a Pre-Approval Inspection (PAI) for the company's Tiotropium DPI ANDA. The inspection at the site was conducted between 08 October 2018 and 18 October 2018.

The inspection closed with five observations. These observations are procedural in nature.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 19 2018 | 3:02 PM IST

Explore News